|
|
||||||||
a Department of Cardiothoracic Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands
b Departments of Congenital Cardiology and Pediatric Cardiology, Erasmus University Medical Center, Rotterdam, The Netherlands
Accepted for publication February 11, 2011.
* Address correspondence to Dr van de Woestijne, Department of Cardiothoracic Surgery, Room Bd 575, Erasmus University Medical Center, PO Box 2040, 3000 CA Rotterdam, The Netherlands (Email: p.vandewoestijne{at}erasmusmc.nl).
Background: In tetralogy of Fallot (TOF) pulmonary regurgitation is a frequent complication after initial repair. The objective of the present study was to describe the long-term experience with the use of allograft conduits for right ventricular outflow tract (RVOT) reconstruction after correction of TOF in our institution.
Methods: Between 1987 and 2009, 133 allografts were implanted in 126 patients (mean age, 27.8 years). The mean time from initial TOF repair to allograft implantation was 20.8 ± 8.8 years. Kaplan-Meier analyses were done for patient survival, freedom from allograft replacement and freedom from any cardiovascular event.
Results: Hospital mortality was 1.5% (2 patients). Mean follow-up was 8.1 years. Ten other patients died during late follow-up, in 8 patients the cause was heart failure. Patient survival was 95% at 5 years, 91% at 10 years, and 80% at 15 years. Male sex, older patient age at the time of operation, and the use of preoperative diuretics were associated with increased risk of mortality during follow-up. Freedom from allograft replacement was 83% at 10 years and 70% at 15 years. Freedom from any valve-related event was 80% at 10 years and 67% at 15 years.
Conclusions: Right ventricular outflow tract reconstruction after previous TOF repair can be performed with low risk and a low reintervention rate. Allograft conduits function satisfactorily in the pulmonary position at longer-term follow-up. Functional status after allograft implantation in patients with a previous correction of TOF remains good. There is concern about the long-term survival and the occurrence of heart failure.
Related Article
Ann. Thorac. Surg. 2011 92: 166.
This article has been cited by other articles:
![]() |
C. Lee, C.-H. Lee, J. G. Kwak, J. Y. Song, W.-S. Shim, E. Y. Choi, S. Y. Lee, and Y. M. Kim Bicuspid pulmonary valve implantation using polytetrafluoroethylene membrane: early results and assessment of the valve function by magnetic resonance imaging Eur J Cardiothorac Surg, March 1, 2013; 43(3): 468 - 472. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Hazekamp Invited Commentary Ann. Thorac. Surg., July 1, 2011; 92(1): 166 - 166. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |